Medicines for all video transcripts
Medicine for all
A global market failure has frustrated the development of safe, effective and affordable new medicines for many underdeveloped and emerging nations.
Key representatives from the United Nations, academia, industry, not for profit and regulatory sectors came together to share insights on how working collaboratively with each other, and those impacted, can begin to address this complex and timeless issue.
"To achieve these goals we will need partnerships. I think in particular that cross-sector partnerships and knowledge partnerships."
"By thinking differently, by thinking creatively, that by engaging through multi sectoral partnerships, that there is a tremendous opportunity for sustainably engaging all nations in delivering health care solutions that 'matter."
"How do you incentivize the private sector and the academic sector, the NGO sector, to start working on these diseases that really are serious threats to our wellbeing?"
"Why do we even do public/private partnerships? Well the answer is that no one entity holds the answers, the expertise or the resources, that's really the bottom line. It is the best business model moving forward."
"Let's put the problem on one side of the table and we all sit together on the other side. That is partnership. It's not the subcontracting of one party by another. It's what two or more parties can each contribute to the overall achievement of the goal."
"We cannot do it alone, the industry cannot do it alone and we need partners to do this, we need partnerships to make this happen."
"I think that it is science that is going to drive developing safe and effective drugs globally by knowing who the patients are in the various countries globally."
"Having input and close participation from the regulators would be the best moving forward."
"To tap into local knowledge, to acknowledge the knowledge that is available."
"Focusing on the sort of big ticket items and the things that can really make a difference."
"We need a new regulatory paradigm where regulators work hand in hand with industry to structure more efficient clinical trials without jeopardizing, of course, the safety and efficacy standards that already exist."
"We're a PDP, a product development partnership, but our job is to bring together multiple partners, multiple stakeholders all with the same objective and to really try and leverage the very best that we can make available. There are drugs out there that are priced as low as thirty-five cents for a cure for a young child. Through partnership we were able to achieve this result."
"With your help, with your input, with your suggestions we need to find additional partners. We have great partners but there are many more out there that help us do this and solve this problem."
Vaccines for all
"To achieve these goals we will need partnerships. I think in particular cross-sector partnerships and knowledge partnerships."
"Two and a half million kids a year die of vaccine preventable deaths. We're going to give you an example of how public/private NGO partnership is attacking that."
"Within PBPN health, the one thing that I'd like to flag besides the fact that our partners and the co-partners share benefits and risk, is that there is a shared objective to create social value and this is a key point of all PBPs, we are all in it ultimately for the social goal that we hope we can generate."
"There are so many challenges that exist in global health specifically for which there are existing solutions."
"We have seen how mobile telephony has transformed lives globally and what we want now is have that revolution come to health and that's what energize the chain is about. Targeting those areas which are hard to reach, where electricity supply is often tenuous if at all. We manage to actually harness the excess energy from our mobile phone towers to actually power these vaccine fridges, maintaining that co-chain."
"The private sector telecom model is dependent on having twenty-four hour power at all of their sites so that they have seamless mobile service. More storage sites are directly linked to an increased number of scheduled immunizations sessions."
"To date, through our program, about two hundred and fifty thousand and five have been vaccinated."
"It's a very low-cost model for a very large impact."
"So really it's about that access, it's about the last mile, closing that gap but ultimately change happens locally and I think there is a real need to better empower existing local forums."
"We want to work with a health partner that has local ownership. We are not trying to shift the health network by any means; we want to increase their efficiency."
"I think that more and more we think about these holistic solutions where we are integrating job creation, access to micro nutrition, access to clean water, access to health services, access to education and thinking about how they interrelate. I think we are going to move closer to systems level change."
"One logical step would be for us to step back and to say okay it is really the infrastructure, it is really the enabling environment that we need to be working with and maybe that is the area of partnership that private and public agencies can work in together."
"With your help, with your input, with your suggestions we need to find additional partners, you saw these great partners but there are many more out there that can help us do this and solve this problem."